##fileformat=VCFv4.0
##source=exLOVD
##reference=GRCh37
##liftOverProgram=CrossMap(https://sourceforge.net/projects/crossmap/)
##liftOverFile=/Volumes/FLASH/UCSC/brca-resources/hg19ToHg38.over.chain.gz
##new_reference_genome=/Volumes/FLASH/UCSC/brca-resources/hg38.fa
##liftOverTime=March25,2017
##INFO=<ID=iarc_class,Number=.,Type=String,Description="Qualitative classification in the 5-grade IARC classification scheme. Class Description:[5 - Definitely pathogenic],Probability of being pathogenic:[>0.99] ; Class Description:[4 - Likely pathogenic],Probability of being pathogenic:[0.95-0.99] ; Class Description:[3 - Uncertain],Probability of being pathogenic:[0.05-0.949] ; Class Description:[2 - Likely not pathogenic or of little clinical significance],Probability of being pathogenic:[0.001-0.049] ; Class Description:[1 - Not pathogenic or of no clinical significance],Probability of being pathogenic:[<0.001]">
##INFO=<ID=db_id,Number=.,Type=String,Description="Database IDentifier.">
##INFO=<ID=segregation_lr,Number=.,Type=String,Description="The likelihood ratio based on segregation analysis.">
##INFO=<ID=combined_prior_p,Number=.,Type=String,Description="The combined prior probability in favor of pathogenicity. is a combination of the missense analysis prior probability and the splicing analysis prior probability. Generally, it is the higher of the two sequence analysis-based prior probabilities.">
##INFO=<ID=sum_family_lr,Number=.,Type=String,Description="The likelihood ratio based on an analysis of the severity of summary family histories of breast and/ or ovarian cancer.">
##INFO=<ID=co_occurrence_lr,Number=.,Type=String,Description="The likelihood ratio based on the frequency of co-occurrence between the variant of interest and clearly pathogenic variants in the same gene.">
##INFO=<ID=protein_change,Number=.,Type=String,Description="Sequence variant name in HGVS protein amino acid sequence based nomenclature. Predicted effect of change on protein (usually without experimental proof!): [?]=unknown ; [(0)]=change expected to abolish translation ; [?fs]=frame shift, but observed phenotype does not fit with prediction (for instance less severe phenotype (BMD) observed, more severe phenotype (DMD) expected) ; [?no fs]=frame shift, but observed phenotype does not fit with prediction (for instance more severe phenotype (DMD) observed, less severe phenotype (BMD) expected) ; [del]=causes deletion ; [fs]=causes frame shift ; [fs?]=effect on reading frame very likely (no experimental proof) ; [(fs?)]=might affect the reading frame (no experimental proof) ; [no fs]=does not cause frame shift ; [X]=stop codon (nonsense).">
##INFO=<ID=key_observational_reference,Number=.,Type=String,Description="Literature source of observational data used in the integrated evaluation displayed here. [Goldgar et al., AJHG 75: 535-544, 2004.], [Tavtigian et al., Human Mutation 29: 1342-1354, 2008.], [Wu, K. et al., Cancer Research 65: 417-426, 2005.], [Tavtigian, S.V. et al., Journal of Medical Genetics 43: 295-305, 2006.], [Chenevix-Trench, G. et al., Cancer Research 66: 2019-2027, 2006.], [Spurdle AB et al., J Clin Oncol, 26: 1657-1663, 2008.], [Easton DF et al., Am J Hum Genet, 81: 873-883, 2007.], [Miki Y et al., Science, 266:66-71, 1994.], [Spearman AD et al., J Clin Oncol, 26:5393-5400, 2008.], [Sweet K et al., Breast Cancer Res Treat, 119:737-743, 2010.], [Lovelock PK et al., J Med Genet, 43:74-83, 2006.], [Osorio A et al., Hum Mutat, 28:477-485, 2007.], [Tischkowitz M et al., Eur J Hum Genet, 16:820-832, 2008.], [Walker LC et al., Human Mutation 31: E1484-E1505, 2010], [Whiley et al., Human Mutation 32: 678-687, 2011], [Domchek SM et al., Cancer Discov 3: 399-405 (2013).], [Thomassen M et al., Breast Cancer Res Treat. 2012 Apr;132(3):1009-23.], [Whiley PJ et al., PLoS One. 2014 Jan 28;9(1):e86836.]">
##INFO=<ID=posterior_p,Number=.,Type=String,Description="Posterior probability in favor of pathogenicity.">
##INFO=<ID=missense_analysis_prior_p,Number=.,Type=String,Description="This prior probability estimate combines position in the protein with an Align-GVGD based evaluation of missense substitutions that fall in the proteins key functional domains.">
##INFO=<ID=dna_change,Number=.,Type=String,Description="Sequence variant name in HGVS cDNA sequence based nomenclature.">
##INFO=<ID=bic_dna_change,Number=.,Type=String,Description="Sequence variant name in older BIC nomenclature.">
##INFO=<ID=pathology_lr,Number=.,Type=String,Description="The likelihood ratio based on tumor pathology and/ or tumor immunohistochemistry.">
##INFO=<ID=exon,Number=.,Type=String,Description="Standard BRCA1 (or BRCA2) exon numbering.">
##INFO=<ID=prior_p_reference,Number=.,Type=String,Description="Literature source of the sequence analysis based prior probability in favor of pathogenicity used in the integrated evaluation displayed here. [Goldgar et al., AJHG 75: 535-544, 2004.], [Tavtigian et al., Human Mutation 29: 1342-1354, 2008.], [Wu, K. et al., Cancer Research 65: 417-426, 2005.], [Tavtigian, S.V. et al., Journal of Medical Genetics 43: 295-305, 2006.], [Chenevix-Trench, G. et al., Cancer Research 66: 2019-2027, 2006.], [Vallee et al., manuscript submitted, 2015]">
##INFO=<ID=product_of_lrs,Number=.,Type=String,Description="The product of all of the likelihood ratios.">
##INFO=<ID=splicing_prior_p,Number=.,Type=String,Description="This prior probability estimate evaluates the sequence variants probability to damage a splice donor, damage a splice acceptor, or create a de novo splice donor.">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
13	32316463	NM_000059:c.3G>A	G	A	.	.	iarc_class=4 - Likely pathogenic;segregation_lr=2.0;combined_prior_p=0.96;sum_family_lr=-;co_occurrence_lr=1.07;protein_change=NM_000059:p.M1I;key_observational_reference=Thomassen M et al., Breast Cancer Res Treat. 2012 Apr, 132(3):1009-23.;posterior_p=0.981;missense_analysis_prior_p=0.96;dna_change=NM_000059:c.3G>A;bic_dna_change=231G>A;pathology_lr=-;exon=2;prior_p_reference=VallÃ©e et al., manuscript submitted, 2015;product_of_lrs=2.14;splicing_prior_p=0.02;BX_ID=1
17	43124044	NM_007294:c.53T>C	A	G	.	.	iarc_class=4 - Likely pathogenic;db_id=BRCA1_00040;segregation_lr=1;combined_prior_p=0.66;sum_family_lr=25.7;co_occurrence_lr=1.23;protein_change=NM_007294:p.M18T;key_observational_reference=Easton et al. 2007;posterior_p=0.9840;missense_analysis_prior_p=0.66;dna_change=NM_007294:c.53T>C;bic_dna_change=172T>C;pathology_lr=-;exon=2;prior_p_reference=Tavtigian et al. 2008;product_of_lrs=31.611;splicing_prior_p=0.01;BX_ID=295
